Core A: Administration
Core A: Administration
批准号:
10522805
负责人:
Reuben S Harris
金额:
$750.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-16 至 2025-04-30
关键词:
2019-nCoVAgreementAnnual ReportsAntiviral AgentsBiometryBudgetsBusinessesCOVID-19 pandemicCOVID-19 treatmentClipCollaborationsCommunicationCommunitiesConflict (Psychology)ConsultConsultationsData AnalysesDecision MakingDevelopmentDisciplineDisease OutbreaksEducational workshopElectronic MailElementsEventExperimental DesignsFutureGeographic LocationsGoalsGrantGroup HomesHuman ResourcesIndividualInternetLeadLeadershipLegalLogisticsMainstreamingMedialMediatingMentorsMidwestern United StatesMindMissionNational Institute of Allergy and Infectious DiseaseOnline SystemsOralOutcomePeer ReviewPharmaceutical PreparationsPublicationsReagentRecommendationReportingResearch DesignResearch PersonnelResearch Project GrantsResource SharingScheduleScientistServicesSiteSpecific qualifier valueStudentsTechnologyTelephoneTimeTrainingTraining ActivityTravelUnited States National Institutes of HealthUpdateViralVirusVotingWorkantiviral drug developmentdrug discoveryexperienceindustry partnermaterial transfer agreementmeetingsmembernew technologynoveloperationorganizational structureoutreachpandemic diseasepaymentpreventprogramsrecruitresearch and developmentsmall moleculesocialsymposiumvirologyweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core A – Administration
ABSTRACT
The primary goals of Core A – Administration are to provide leadership, logistical support, and coordinated
communication for all members and collaborators of the Midwest AViDD Center in order to expedite the
successful completion of all specific aims. The PI of Core A is Reuben Harris and the Co-I is Fang Li, which
mirrors the overall leadership arrangement with Dr. Harris as corresponding Co-PI and Li as Co-PI. The specific
aims of Core A are to 1) provide strong and consistent leadership; 2) provide services to Program scientists,
collaborators, industry partners, and Scientific Advisory Board (SAB) members; and 3) coordinate center
communications including meetings, workshops, and outreach efforts. The efficient administration of this multi-
institutional team is essential for the successful development of novel small molecules with potential to become
orally available drugs to treat SARS-CoV-2 (all projects) and other viruses with pandemic concern (at least one
other virus to be targeted by each project).
Harris and Li both have experience managing multi-investigator, matrixed grants, and they meet weekly to
coordinate center management. They are supported by a full-time Executive Administrative Coordinator, who
provides day-to-day administrative support and coordinates meetings, workshops, travel and other
communication and networking activities. The Executive Leadership Team (ExLT), which consists of Project and
Core PIs, meets monthly to review the status of scientific progress and discuss administrative business including
budgets. The ExLT will also receive quarterly go/no-go recommendations on hit-to-lead (H2L) advancement from
the HTL Committee, which may trigger appropriate budget adjustments. Core A will also coordinate an annual
workshop for all center personnel, Scientific Advisory Board (SAB) members, and Industry Partners on dates
juxtaposing an anticipated pan-AViDD consortium meeting at the NIH campus. The SAB will be appointed with
consultation from NIAID AViDD network leadership and will participate in the annual workshop and other
meetings as required by NIAID. Additional meetings of PIs, Project personnel, Core personnel, outside
collaborators, and all center-associated personnel occur on a biweekly or monthly basis as specified by each
component. Web-based zoom meetings facilitate the participation of all team members regardless of geographic
location.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Midwest AViDD Center
-
批准号:10631659
-
项目类别:
-
资助金额:$45.68万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Midwest AViDD Center
-
批准号:10522804
-
项目类别:
-
资助金额:$6643.12万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Administrative-Core-001
-
批准号:10707575
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Project 3: Pandemic Virus Protease Inhibitors
-
批准号:10522812
-
项目类别:
-
资助金额:$288.0万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:10474975
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10474974
-
项目类别:
-
资助金额:$175.12万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:10916617
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10738334
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:9804091
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10225387
-
项目类别:
-
资助金额:$171.35万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10676574
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:9804090
-
项目类别:
-
资助金额:$165.65万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:10225388
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
2017 RNA Editing Gordon Research Conference and Gordon Research Seminar
-
批准号:9331005
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2017
-
负责人:Reuben S Harris
-
依托单位:
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
-
批准号:9127434
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2016
-
负责人:Reuben S Harris
-
依托单位:
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
-
批准号:9271943
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2016
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8233319
-
项目类别:
-
资助金额:$193.3万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8433365
-
项目类别:
-
资助金额:$199.77万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8689415
-
项目类别:
-
资助金额:$2.03万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8536529
-
项目类别:
-
资助金额:$8.41万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
海外基金